Active Startup: Laurent Pharma

News

Published: 10Oct2019

Business Snapshot
Company has developed a clinical stage, orally-active drug candidate with the potential to modulate the immuno-inflammatory response in cystic fibrosis patients.

Target Markets
Cystic fibrosis

Intellectual Property
Patents around the world

Founder
Danuta Radzioch, Radu Pislariu

Back to top